Advanced Good Cell Culture Practice for human primary, stem cell-derived and organoid models as well as microphysiological systems
Advanced Good Cell Culture Practice for human primary, stem cell-derived and organoid models as well as microphysiological systems
Date
2018
Authors
Pamies, David
Bal-Price, Anna K.
Chesné, Christophe
Coecke, Sandra
Dinnyes, Andras
Eskes, Chantra
Grillari, Regina
Editors
Journal ISSN
Electronic ISSN
ISBN
Bibliographical data
Publisher
Series
URI (citable link)
DOI (citable link)
International patent number
Link to the license
EU project number
681002
Project
EUToxRisk21
Open Access publication
Collections
Title in another language
Publication type
Journal article
Publication status
Published
Published in
Alternatives to Animal Experimentation : ALTEX ; 35 (2018), 3. - pp. 353-378. - ISSN 1868-596X. - eISSN 1868-8551
Abstract
A major reason for the current reproducibility crisis in the life sciences is the poor implementation of quality control measures and reporting standards. Improvement is needed, especially regarding increasingly complex in vitro methods. Good Cell Culture Practice (GCCP) was an effort from 1996 to 2005 to develop such minimum quality standards also applicable in academia. This paper summarizes recent key developments in in vitro cell culture and addresses the issues resulting for GCCP, e.g. the development of induced pluripotent stem cells (iPSCs) and gene-edited cells. It further deals with human stem-cell-derived models and bioengineering of organo-typic cell cultures, including organoids, organ-on-chip and human-on-chip approaches. Commercial vendors and cell banks have made human primary cells more widely available over the last decade, increasing their use, but also requiring specific guidance as to GCCP. The characterization of cell culture systems including high-content imaging and high-throughput measurement technologies increasingly combined with more complex cell and tissue cultures represent a further challenge for GCCP. The increasing use of gene editing techniques to generate and modify in vitro culture models also requires discussion of its impact on GCCP. International (often varying) legislations and market forces originating from the commercialization of cell and tissue products and technologies are further impacting on the need for the use of GCCP. This report summarizes the recommendations of the second of two workshops, held in Germany in December 2015, aiming map the challenge and organize the process or developing a revised GCCP 2.0.
Summary in another language
Subject (DDC)
570 Biosciences, Biology
Keywords
quality control, cell culture, in vitro methods, gene editing, organotypic
Conference
Review
undefined / . - undefined, undefined. - (undefined; undefined)
Cite This
ISO 690
PAMIES, David, Anna K. BAL-PRICE, Christophe CHESNÉ, Sandra COECKE, Andras DINNYES, Chantra ESKES, Regina GRILLARI, Thomas HARTUNG, Marcel LEIST, Mardas DANESHIAN, 2018. Advanced Good Cell Culture Practice for human primary, stem cell-derived and organoid models as well as microphysiological systems. In: Alternatives to Animal Experimentation : ALTEX. 35(3), pp. 353-378. ISSN 1868-596X. eISSN 1868-8551. Available under: doi: 10.14573/altex.1710081BibTex
@article{Pamies2018Advan-42847, year={2018}, doi={10.14573/altex.1710081}, title={Advanced Good Cell Culture Practice for human primary, stem cell-derived and organoid models as well as microphysiological systems}, number={3}, volume={35}, issn={1868-596X}, journal={Alternatives to Animal Experimentation : ALTEX}, pages={353--378}, author={Pamies, David and Bal-Price, Anna K. and Chesné, Christophe and Coecke, Sandra and Dinnyes, Andras and Eskes, Chantra and Grillari, Regina and Hartung, Thomas and Leist, Marcel and Daneshian, Mardas} }
RDF
<rdf:RDF xmlns:dcterms="http://purl.org/dc/terms/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:bibo="http://purl.org/ontology/bibo/" xmlns:dspace="http://digital-repositories.org/ontologies/dspace/0.1.0#" xmlns:foaf="http://xmlns.com/foaf/0.1/" xmlns:void="http://rdfs.org/ns/void#" xmlns:xsd="http://www.w3.org/2001/XMLSchema#" > <rdf:Description rdf:about="https://kops.uni-konstanz.de/server/rdf/resource/123456789/42847"> <bibo:uri rdf:resource="https://kops.uni-konstanz.de/handle/123456789/42847"/> <dc:contributor>Daneshian, Mardas</dc:contributor> <dc:creator>Daneshian, Mardas</dc:creator> <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2018-07-11T14:28:22Z</dc:date> <dspace:hasBitstream rdf:resource="https://kops.uni-konstanz.de/bitstream/123456789/42847/1/Pamies_2-tidi7bve3p0l8.pdf"/> <dc:contributor>Chesné, Christophe</dc:contributor> <dc:creator>Coecke, Sandra</dc:creator> <dc:contributor>Eskes, Chantra</dc:contributor> <dc:contributor>Coecke, Sandra</dc:contributor> <dc:creator>Grillari, Regina</dc:creator> <dcterms:abstract xml:lang="eng">A major reason for the current reproducibility crisis in the life sciences is the poor implementation of quality control measures and reporting standards. Improvement is needed, especially regarding increasingly complex in vitro methods. Good Cell Culture Practice (GCCP) was an effort from 1996 to 2005 to develop such minimum quality standards also applicable in academia. This paper summarizes recent key developments in in vitro cell culture and addresses the issues resulting for GCCP, e.g. the development of induced pluripotent stem cells (iPSCs) and gene-edited cells. It further deals with human stem-cell-derived models and bioengineering of organo-typic cell cultures, including organoids, organ-on-chip and human-on-chip approaches. Commercial vendors and cell banks have made human primary cells more widely available over the last decade, increasing their use, but also requiring specific guidance as to GCCP. The characterization of cell culture systems including high-content imaging and high-throughput measurement technologies increasingly combined with more complex cell and tissue cultures represent a further challenge for GCCP. The increasing use of gene editing techniques to generate and modify in vitro culture models also requires discussion of its impact on GCCP. International (often varying) legislations and market forces originating from the commercialization of cell and tissue products and technologies are further impacting on the need for the use of GCCP. This report summarizes the recommendations of the second of two workshops, held in Germany in December 2015, aiming map the challenge and organize the process or developing a revised GCCP 2.0.</dcterms:abstract> <dc:creator>Leist, Marcel</dc:creator> <dcterms:hasPart rdf:resource="https://kops.uni-konstanz.de/bitstream/123456789/42847/1/Pamies_2-tidi7bve3p0l8.pdf"/> <dc:contributor>Leist, Marcel</dc:contributor> <dc:creator>Hartung, Thomas</dc:creator> <dc:creator>Eskes, Chantra</dc:creator> <dc:contributor>Bal-Price, Anna K.</dc:contributor> <dcterms:isPartOf rdf:resource="https://kops.uni-konstanz.de/server/rdf/resource/123456789/28"/> <dc:rights>Attribution 4.0 International</dc:rights> <foaf:homepage rdf:resource="http://localhost:8080/"/> <dcterms:rights rdf:resource="http://creativecommons.org/licenses/by/4.0/"/> <void:sparqlEndpoint rdf:resource="http://localhost/fuseki/dspace/sparql"/> <dspace:isPartOfCollection rdf:resource="https://kops.uni-konstanz.de/server/rdf/resource/123456789/28"/> <dc:contributor>Hartung, Thomas</dc:contributor> <dcterms:issued>2018</dcterms:issued> <dc:language>eng</dc:language> <dc:creator>Bal-Price, Anna K.</dc:creator> <dc:creator>Pamies, David</dc:creator> <dc:contributor>Grillari, Regina</dc:contributor> <dc:creator>Dinnyes, Andras</dc:creator> <dc:creator>Chesné, Christophe</dc:creator> <dc:contributor>Dinnyes, Andras</dc:contributor> <dc:contributor>Pamies, David</dc:contributor> <dcterms:available rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2018-07-11T14:28:22Z</dcterms:available> <dcterms:title>Advanced Good Cell Culture Practice for human primary, stem cell-derived and organoid models as well as microphysiological systems</dcterms:title> </rdf:Description> </rdf:RDF>
Internal note
xmlui.Submission.submit.DescribeStep.inputForms.label.kops_note_fromSubmitter
Examination date of dissertation
Method of financing
Comment on publication
Alliance license
Corresponding Authors der Uni Konstanz vorhanden
International Co-Authors
Bibliography of Konstanz
Yes
Refereed
Yes